Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI – Get Rating) was the recipient of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 78,900 shares, a growth of 71.5% from the April 30th total of 46,000 shares. Currently, 1.2% of the company’s stock are sold short. Based […]
Sema4 Holdings Corp. (NASDAQ:SMFR – Get Rating) insider Eric Schadt acquired 100,000 shares of the company’s stock in a transaction dated Friday, May 20th. The shares were bought at an average price of $1.92 per share, for a total transaction of $192,000.00. Following the purchase, the insider now owns 243,380 shares in the company, valued […]
Sema4 (NASDAQ:SMFR – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Sema4 Holdings Corp is a patient-centered health intelligence company. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic […]